Mark D. Vincent - Feb 5, 2024 Form 4 Insider Report for Aptose Biosciences Inc. (APTO)

Role
Director
Signature
/s/ Mark D. Vincent
Stock symbol
APTO
Transactions as of
Feb 5, 2024
Transactions value $
$0
Form type
4
Date filed
2/7/2024, 04:50 PM
Previous filing
Jan 23, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APTO Director Stock Option (Right to Buy) Award $0 +3.33K $0.00 3.33K Feb 5, 2024 Common Shares 3.33K $1.97 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Converted from Canadian exercise price of C$2.67 using an exchange rate of C$1.3527 = US$1.00.
F2 The options vest as follows: 50% on February 5, 2025; 25% on February 5, 2026; and 25% on February 5, 2027.